HK1209350A1 - Use of bacteroides caccae in the treatment or prevention of rheumatoid arthritis or related diseases - Google Patents

Use of bacteroides caccae in the treatment or prevention of rheumatoid arthritis or related diseases

Info

Publication number
HK1209350A1
HK1209350A1 HK15110144.7A HK15110144A HK1209350A1 HK 1209350 A1 HK1209350 A1 HK 1209350A1 HK 15110144 A HK15110144 A HK 15110144A HK 1209350 A1 HK1209350 A1 HK 1209350A1
Authority
HK
Hong Kong
Prior art keywords
prevention
treatment
rheumatoid arthritis
related diseases
bacteroides caccae
Prior art date
Application number
HK15110144.7A
Other languages
Chinese (zh)
Inventor
馮强張東亞賈慧珏劉傳肖亮王俊
Original Assignee
146 11F 3
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 146 11F 3 filed Critical 146 11F 3
Publication of HK1209350A1 publication Critical patent/HK1209350A1/en

Links

HK15110144.7A 2014-09-30 2015-10-15 Use of bacteroides caccae in the treatment or prevention of rheumatoid arthritis or related diseases HK1209350A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410522408.5A CN104546933A (en) 2014-09-30 2014-09-30 Application of bacteroides caccae in treatment or prevention of rheumatoid arthritis or related diseases thereof

Publications (1)

Publication Number Publication Date
HK1209350A1 true HK1209350A1 (en) 2016-04-01

Family

ID=53064705

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15110144.7A HK1209350A1 (en) 2014-09-30 2015-10-15 Use of bacteroides caccae in the treatment or prevention of rheumatoid arthritis or related diseases

Country Status (2)

Country Link
CN (1) CN104546933A (en)
HK (1) HK1209350A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
KR20220151045A (en) 2014-12-23 2022-11-11 4디 파마 리서치 리미티드 Immune modulation
SG10202105996WA (en) 2014-12-23 2021-07-29 4D Pharma Res Ltd Pirin polypeptide and immune modulation
MA41010B1 (en) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprising bacterial strains
RS59308B1 (en) 2015-06-15 2019-10-31 4D Pharma Res Ltd Compositions comprising bacterial strains
PL3206700T3 (en) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprising bacterial strains
MA41060B1 (en) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprising bacterial strains
MD3240554T2 (en) 2015-06-15 2020-01-31 4D Pharma Res Ltd Blautia stercosis and wexlerae for use in treating inflammatory and autoimmune diseases
ME03003B (en) 2015-11-20 2018-10-20 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
RS58869B1 (en) 2016-03-04 2019-08-30 4D Pharma Plc Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
TW201821093A (en) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 Compositions comprising bacterial strains
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
WO2018107365A1 (en) * 2016-12-13 2018-06-21 深圳华大基因研究院 Anaerostipes caccae and applications thereof
TWI787272B (en) 2017-05-22 2022-12-21 英商4D製藥研究有限公司 Compositions comprising bacterial strains
JP6978514B2 (en) 2017-05-24 2021-12-08 フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited Composition containing bacterial strain
JP6884889B2 (en) 2017-06-14 2021-06-09 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ Compositions Containing Bacterial Strains
KR20200015575A (en) 2017-06-14 2020-02-12 4디 파마 리서치 리미티드 Compositions Containing Bacterial Strains

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1920781B1 (en) * 2006-11-10 2015-03-04 Glycotope GmbH Compositions comprising a core-1 positive microorganism and their use for the treatment or prophylaxis of tumors
WO2009095840A1 (en) * 2008-01-31 2009-08-06 Koninklijke Philips Electronics N. V. Method for simultaneous detection of pathogens and genetic profiling of the host using a single array
CA2836413A1 (en) * 2010-06-01 2011-12-08 Moore Research Enterprises Llc Cellular constituents from bacteroides, compositions thereof, and therapeutic methods employing bacteroides or cellular constituents thereof

Also Published As

Publication number Publication date
CN104546933A (en) 2015-04-29

Similar Documents

Publication Publication Date Title
HK1209350A1 (en) Use of bacteroides caccae in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209347A1 (en) Use of bacteroides dorei in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209360A1 (en) Use of bacteroides ovatus in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209365A1 (en) Use of bacteroides plebeius in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209348A1 (en) Use of bacteroides thetaiotaomicron in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209349A1 (en) Use of parabacteroides merdae in the treatment or prevention of rheumatoid arthritis or related diseases
HUE051071T2 (en) Use of cannabidiol in the treatment of tuberous sclerosis complex
GB201411496D0 (en) Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy
ZA201707303B (en) Compositions and methods for the treatment of immunodeficiency
GB201415261D0 (en) Water Tap Body And Instillation
EP3202892A4 (en) Uses of bacteroides in treatment or prevention of obesity-related diseases
HK1249851A1 (en) Treatment and prevention of the common cold using povidone-iodine
HK1209346A1 (en) Use of bifidobacterium bifidum in the treatment or prevention of rheumatoid arthritis or related diseases
PT3160464T (en) 6-hydroxybuspirone for use in the treatment of movement disorders
HK1209351A1 (en) Use of haemophilus parainfluenzae in the treatment or prevention of rheumatoid arthritis or related diseases
FI3197556T3 (en) Composition for the prevention and/or treatment of allergy symptoms
EP3202891A4 (en) Uses of bacteroides in treatment or prevention of obesity-related diseases
HK1209359A1 (en) Use of megamonas hypermegale in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209366A1 (en) Use of lactococcus lactis in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209363A1 (en) Use of lactobacillus crispatus in the treatment or prevention of rheumatoid arthritis or related diseases
HK1246271A1 (en) Method for the synthesis of hydroxy-triglycerides and uses thereof for the prevention and treatment of diseases
HK1209357A1 (en) Use of dialister invisus in the treatment or prevention of rheumatoid arthritis or related diseases
IL252493A0 (en) Compounds for use in the prevention or treatment of cancer
PT3191112T (en) Dipeptidyl ketoamide compounds and their use for the treatment and/or prevention of fat accumulation
HK1209369A1 (en) Use of alistipes shahii in the treatment or prevention of rheumatoid arthritis or related diseases